Exchange: NYSE
Industry: Drug Manufacturers/Other
Last Trade: 4:03 PM ET 2/9/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.60 | 0.40 | 50.00 |
| EPS, GAAP | 0.37 | 0.38 | -2.63 |
| Consensus Estimate | NA | NA | NA |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 1.70 | 1.46 | 16.44 |
| EPS, GAAP | 1.52 | 0.21 | 623.81 |
| Consensus Estimate | NA | NA | NA |
| RDY | Industry Average | |
| P/E (TTM) | 21.53 | 29.30 |
| P/E (Forward) | 17.50 | 14.20 |
| PEG Ratio | 0.70 | 0.72 |
| Price/Sales | 3.12 | 4.56 |
| Beta | 1.10 | 0.90 |
| 6:06 AM | 2/3/2012 | UPDATE: Dr Reddy's Laboratories 3Q Net Profit Soars 88%; Tops View |
| 4:06 AM | 2/3/2012 | Dr Reddy's Laboratories 3Q Net Profit Soars 88%, Beats Estimates |
| 2/8/2012 | Top Analyst Upgrades & Downgrades (NLY, MT, BP, CBOE, DMD, RDY, ING, MS, NOV, OPEN, SOHU, UBS, VSH, YUM) (24/7 Wall St) |
| 2/7/2012 | Look for income from BRIC countries. (The Motley Fool) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)
